Hosted on MSN
Cipla slides 5% in two days after management reshuffle; Q2 PAT rises 4% YoY to Rs 1,353 cr
Key therapies in the branded prescription business continued to deliver strong market growth, and with the launch of Yurpeak ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback